StockData
908 Devices Inc. logo

908 Devices Inc. (MASS) company profile

MASSNasdaqLaboratory Analytical InstrumentsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 10/3041% above fair value
$9.39+0.20 (+2.18%)

Close on Nov 17, 2026Market cap $388.12MP/E –Yield –

About 908 Devices

Laboratory Analytical Instruments, SIC 3826

908 Devices develops and manufactures portable devices for chemical analysis at the point of need using mass spectrometry and optical spectroscopy technologies. Its portfolio includes handheld instruments such as the MX908, ThreatID, ProtectIR, XplorIR, and VipIR, alongside sampling consumables, extended warranty plans, on-site training, and round-the-clock technical support. The business serves government and life sciences markets, providing measurement tools to civilian first responders, military personnel, hazmat teams, customs and border agents, and law enforcement officers.

The company has deployed more than 3,700 devices across all fifty U.S. states and five continents to over 700 customer accounts. Commercial reach includes a direct North American sales organization and more than 64 domestic and international distribution partners. Primary manufacturing takes place in Danbury, Connecticut, supported by machining sites in Stamford, Connecticut, and Georgetown, Massachusetts, as well as research facilities in Burlington, Massachusetts, and Danbury. The text does not specify a corporate headquarters location.

Summary of the business section of 908 Devices's latest annual report, written by StockData.

Company profile

Company

Legal name
908 Devices Inc.
Founded
2012
Headquarters
Burlington, MA
Address
44 Third Avenue 01803
Phone
(978) 729-4478
Employees
172, Dec 31, 2025
Industry
Laboratory Analytical Instruments
Incorporated in
Delaware
Fiscal year ends
December 31
Auditor
PricewaterhouseCoopers, LLP, Boston, Massachusetts

Stock & identifiers

Ticker
MASS
Exchange
Nasdaq
IPO date
Dec 18, 2020
Shares outstanding
41M, Aug 7, 2026
Public float
$194.90M, Jun 30, 2025
Filer category
Non-accelerated filer<br>Smaller reporting company
SEC CIK
1555279
CUSIP
65443P102
ISIN
US65443P1021
FIGI
BBG008N1BYQ9
Share class FIGI
BBG008N1BYS7
EIN
45-4524096

Executives and directors

Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years

NamePositionShares owned
Kevin J. KnoppPresident and CEO, Director1,097,191
Joseph H. Griffith IVChief Financial Officer116,497
John KennewegSVP, Sales & Product Marketing57,784
Kolawole A. OtitojuChief Bus. & Strategy Officer–
Kevin J. McCallionSVP, Products and Production44,925
Mark S. LevineChief Legal and Admin. Officer–
Michael S. TurnerChief Legal & Admin Officer0
Christopher D. BrownDirector775,559
Brandi C. VannDirector5,192
Michele M. LeonhartDirector27,054
Anthony HuntDirector44,168
E. Kevin HrusovskyDirector495,065
Mark SpotoDirector92,945
Fenel M. EloiDirector40,897
Keith CrandellDirector5,764,419
Jeffrey P. GeorgeDirector26,814
Marcia EisenbergDirector25,957

CEO pay and shareholder return

Pay versus performance table from the proxy statement

Fiscal yearCEO total payCEO pay actually paidOther executives (avg)Value of $100 investedPeer group
FY2025$1.55M$3.05M$1.24M$47–
FY2024$1.99M$29.39K$1.22M$20–

“Actually paid” adjusts reported pay for changes in the value of equity awards. Shareholder return assumes $100 invested at the start of the measurement period, as disclosed by the company.

Executive compensation, fiscal 2025

Summary compensation table from the latest proxy statement

ExecutiveSalaryBonusStock awardsOption awardsIncentive payOtherTotalvs. prior year
Kevin J. Knopp, Ph.D.
President and Chief Executive Officer
$500.00K–$393.75K$131.25K$525.00K$3.50K$1.55M-22%
Joseph H. Griffith IV
Chief Financial Officer and Treasurer
$378.35K$200.00K$258.23K$86.08K$214.90K$3.50K$1.14M-8%
Mark S. Levine
Chief Legal and Administrative Officer and Secretary
$21.64K–$656.26K$656.25K––$1.33M–

Stock and option awards are grant-date fair values, not realized pay. “Other” includes pension value changes and all other compensation. Source proxy statement.

IPO

From the final prospectus (Form 424B4) and the first day of trading

Offering

Type
Initial public offering
Final prospectus filed
Dec 18, 2020
Offer price
$20.00
Securities offered
6,500,000
Gross proceeds
$130.00M
Exchange
Nasdaq
First trading day
Dec 18, 2020
First-day close
$49.00+145.0%
Lock-up ends (est.)
Jun 16, 2021

“The initial public offering price is $20.00 per share.”

Lock-up end is estimated as 180 days after the first trading day; the prospectus sets the actual terms.

Employees

Headcount reported in annual reports

“As of December 31, 2025, we had 172 full-time employees, of which 35 work in sales, sales support and marketing, 43 work in engineering and research and development, 62 work in manufacturing, operations and service and 32 work in general and administrative.”

Corporate history

Events identified from SEC filings

See a number that looks wrong?